Prepared by Dr. Marcus Thorne, FRM, Head of Quantitative Research | Reviewed by Yuki Tanaka, Lead Editor | Report ID: IGEMINI-CD091DC3-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns margin trading calculator a Cautiously Constructive outlook for the next quarter. Key drivers include a P/E of 85.81x, -7% revenue expansion, and an RSI of 69 suggesting a neutral-bullish phase. We define critical support at $1392.3 and resistance at $1701.7.
Rating: Outperform | Target Price: $1732.64 | Next Earnings: Jul 10
Download Full PDF Report
MACD printed a Bullish Crossover as the 50-day SMA turned positive 20 days ago.
Price action carved a Bull Flag, confirmed by a 1.03x volume spike on May 08, 2026. The support at $1701.7 was tested.
EPS of $18.03 reveals high earnings quality. DuPont analysis highlights operating leverage as the key ROE driver.
Relative to Healthcare peers, margin trading calculator sits at the 74th percentile in valuation, offering a potential value opportunity.
Free cash flow conversion remains robust at 77%, supporting the 0.07% dividend and buybacks.
Options skew is toward call at the 1686.23 strike, positioning for a directional move.
Short float at 14.2% is below the sector average, reducing squeeze risk. Institutional ownership is 90%.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $1547 | $1469.65 |
| Market Cap | $24.51B | $26.96B |
| P/E Ratio | 85.81x | 72.9x |
| EPS (TTM) | $18.03 | $16.23 |
| Dividend Yield | 0.07% | 0% |
| Revenue Growth | -7% | -4.2% |
| Target Price | $1732.64 | - |
| Beta | 0.81 | 1.00 |